Temam S, Varraso R, Pornet C, Sanchez M, Affret A, Jacquemin B, et al. Ability of ecological deprivation indices to measure social inequalities in a French cohort. BMC Public Health. 2017 Dec 15;17(1):956.
Ghosn W, Menvielle G, Rican S, Rey G. Associations of cause-specific mortality with area level deprivation and travel time to health care in France from 1990 to 2007, a multilevel analysis. BMC Public Health. 2017 Aug 2;18(1):86.
Mercereau L, Todd N, Rey G, Valleron AJ. Comparison of the temperature-mortality relationship in foreign born and native born died in France between 2000 and 2009. Int J Biometeorol. 2017 May 25;
Pouessel G, Claverie C, Labreuche J, Dorkenoo A, Renaudin JM, Eb M, et al. Fatal anaphylaxis in France: analysis of national anaphylaxis data, 1979-201J Allergy Clin Immunol. 2017 Mar 7;
Ngantcha M, Le-Pogam MA, Calmus S, Grenier C, Evrard I, Lamarche-Vadel A, et al. Hospital quality measures: are process indicators associated with hospital standardized mortality ratios in French acute care hospitals? BMC Health Serv Res. 2017 Aug 22;17(1):578.
Elhai M, Meune C, Boubaya M, Avouac J, Hachulla E, Balbir-Gurman A, et al. Mapping and predicting mortality from systemic sclerosis. Ann Rheum Dis. 2017 Aug 23;
Avouac J, Amrouche F, Meune C, Rey G, Kahan A, Allanore Y. Mortality profile of patients with rheumatoid arthritis in France and its change in 10 years. Semin Arthritis Rheum. 2017 Apr;46(5):537–43.
Affret A, Severi G, Dow C, Rey G, Delpierre C, Boutron-Ruault MC, et al. Socio-economic factors associated with a healthy diet: results from the E3N study. Public Health Nutr. 2017 Jun;20(9):1574–83.
Moreno-Betancur M, Sadaoui H, Piffaretti C, Rey G. Survival Analysis with Multiple Causes of Death: Extending the Competing Risks Model. Epidemiology. 2017 Jan;28(1):12–9.
de Saint Maurice G, Aouba A, Pequignot F, Auroy Y, Benhamou D, Jougla E, et al. Anesthesia-related mortality. Anesthesiology. 2009 Nov;111(5):1165; author reply 1166.
Bonnet F, Burty C, Lewden C, Costagliola D, May T, Bouteloup V, et al. Changes in cancer mortality among HIV-infected patients: the Mortalité 2005 Survey. Clin Infect Dis. 2009 Mar 1;48(5):633–9.
Fuhrman C, Jougla E, Uhry Z, Delmas MC. Deaths with asthma in France, 2000-2005: a multiple-cause analysis. J Asthma. 2009 May;46(4):402–6.
Alpérovitch A, Bertrand M, Jougla E, Vidal JS, Ducimetière P, Helmer C, et al. Do we really know the cause of death of the very old? Comparison between official mortality statistics and cohort study classification. Eur J Epidemiol. 2009;24(11):669–75.
Rey G, Jougla E, Fouillet A, Hémon D. Ecological association between a deprivation index and mortality in France over the period 1997 - 2001: variations with spatial scale, degree of urbanicity, age, gender and cause of death. BMC Public Health. 2009;9:33.
Salmon-Ceron D, Rosenthal E, Lewden C, Bouteloup V, May T, Burty C, et al. Emerging role of hepatocellular carcinoma among liver-related causes of deaths in HIV-infected patients: The French national Mortalité 2005 study. J Hepatol. 2009 Apr;50(4):736–45.
Rey G, Fouillet A, Bessemoulin P, Frayssinet P, Dufour A, Jougla E, et al. Heat exposure and socio-economic vulnerability as synergistic factors in heat-wave-related mortality. Eur J Epidemiol. 2009;24(9):495–502.
Lanoy E, Lewden C, Lièvre L, Tattevin P, Boileau J, Aouba A, et al. How does loss to follow-up influence cohort findings on HIV infection? A joint analysis of the French hospital database on HIV, Mortalité 2000 survey and death certificates. HIV Med. 2009 Apr;10(4):236–45.
de Saint Maurice G, Pequignot F, Auroy Y, Aouba A, Benhamou D, Jougla E, et al. Patient blood management and transfusion. Anesthesiology. 2009 Aug;111(2):444–5; author reply 445-446.
Ziadé N, Jougla E, Coste J. Using vital statistics to estimate the population-level impact of osteoporotic fractures on mortality based on death certificates, with an application to France (2000-2004). BMC Public Health. 2009;9:344.
Carbonneil C, Donkova-Petrini V, Aouba A, Weiss L. Defective dendritic cell function in HIV-infected patients receiving effective highly active antiretroviral therapy: neutralization of IL-10 production and depletion of CD4+CD25+ T cells restore high levels of HIV-specific CD4+ T cell responses induced by dendritic cells generated in the presence of IFN-alpha. J Immunol. 2004 Jun 15;172(12):7832–40.
Bouvier AM, Remontet L, Jougla E, Launoy G, Grosclaude P, Buémi A, et al. Incidence of gastrointestinal cancers in France. Gastroenterol Clin Biol. 2004 Oct;28(10 Pt 1):877–81.
Bonnet F, Lewden C, May T, Heripret L, Jougla E, Bevilacqua S, et al. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. Cancer. 2004 Jul 15;101(2):317–24.